Dvorak H F, Gresser I
Beth Israel Hospital, Harvard Medical School, Boston, MA.
J Natl Cancer Inst. 1989 Apr 5;81(7):497-502. doi: 10.1093/jnci/81.7.497.
DBA/2 mice were injected sc with cells from the highly malignant Friend erythroleukemia cell (FLC) 3Cl8 subline, which is resistant to mouse interferon alpha/beta, or with the ESb lymphoma. When interferon alpha/beta was injected intratumorally or peritumorally, tumor growth was markedly suppressed, and established vascularized tumor nodules became progressively necrotic. Tumor necrosis was of the coagulation type that usually results from deprivation of blood flow. Morphologic examination of approximately 1,000 blood vessel profiles and approximately 2,000 endothelial cells in 1-micron Epon sections of sc 3C18 FLC tumors showed that interferon treatment resulted in rapid and pronounced vascular endothelial cell damage that preceded tumor necrosis. No inflammatory cell infiltrate was observed. Our results suggest that interferon alpha/beta exerted an antitumor effect in these tumor models by damaging tumor blood vessels, causing disruption of tumor blood flow, which led to ischemic tumor necrosis.
给DBA/2小鼠皮下注射来自高度恶性的Friend红白血病细胞(FLC)3Cl8亚系(对小鼠α/β干扰素耐药)的细胞,或ESb淋巴瘤细胞。当α/β干扰素瘤内或瘤周注射时,肿瘤生长明显受到抑制,已形成血管的肿瘤结节逐渐坏死。肿瘤坏死为凝血型,通常是由于血流阻断所致。对皮下3C18 FLC肿瘤1微米厚环氧树脂切片中约1000个血管轮廓和约2000个内皮细胞进行形态学检查显示,干扰素治疗导致肿瘤坏死之前血管内皮细胞迅速且明显受损。未观察到炎性细胞浸润。我们的结果表明,α/β干扰素在这些肿瘤模型中通过损伤肿瘤血管、导致肿瘤血流中断,进而引起缺血性肿瘤坏死发挥抗肿瘤作用。